European Urology Oncology

Scope & Guideline

Driving interdisciplinary collaboration for better patient outcomes.

Introduction

Immerse yourself in the scholarly insights of European Urology Oncology with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN-
PublisherELSEVIER
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationEUR UROL ONCOL / Eur. Urol. Oncol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'European Urology Oncology' is dedicated to advancing knowledge in the field of urologic oncology, focusing on the latest research and clinical practices related to the diagnosis, treatment, and management of urologic cancers. The journal emphasizes a multidisciplinary approach, integrating various aspects of urology, oncology, and pathology to improve patient outcomes.
  1. Prostate Cancer Research:
    The journal covers extensive research on prostate cancer, including advanced treatment options, diagnostic techniques, and the role of biomarkers in predicting outcomes.
  2. Bladder Cancer Studies:
    Significant attention is given to bladder cancer, focusing on surgical techniques, immunotherapy, and the efficacy of various treatment regimens.
  3. Renal Cell Carcinoma Insights:
    Research on renal cell carcinoma encompasses clinical trials, treatment strategies, and the molecular characteristics of the disease.
  4. Emerging Diagnostic Technologies:
    The journal highlights advancements in imaging techniques such as MRI and PET scans, which are crucial for accurate diagnosis and treatment planning.
  5. Health Economics and Quality of Life:
    There is a focus on assessing the cost-effectiveness of treatments and understanding the impact of cancer therapies on patients' quality of life.
  6. Multidisciplinary Approaches:
    The journal promotes collaborative research efforts, integrating insights from urologists, oncologists, radiologists, and pathologists to enhance treatment outcomes.
The journal 'European Urology Oncology' is at the forefront of addressing emerging trends and themes in urologic oncology, reflecting the evolving landscape of research priorities and clinical practices.
  1. Immunotherapy and Targeted Therapies:
    There is a growing focus on immunotherapeutic approaches and targeted therapies, particularly in the treatment of advanced prostate and bladder cancers, indicating a shift towards more personalized medicine.
  2. Liquid Biopsy and Biomarkers:
    Emerging trends highlight the use of liquid biopsies and genomic biomarkers for early detection and monitoring of treatment response, showcasing advancements in non-invasive diagnostic technologies.
  3. Artificial Intelligence in Oncology:
    The integration of artificial intelligence and machine learning in diagnostics and treatment planning is gaining traction, with studies exploring their applications in improving patient outcomes.
  4. Health Disparities and Access to Care:
    An increasing number of articles address health disparities in cancer care, focusing on access to treatments and the socioeconomic factors affecting patient outcomes.
  5. Quality of Life Assessments:
    Research emphasizing the importance of patient-reported outcomes and quality of life in treatment decision-making is on the rise, reflecting a holistic approach to cancer care.

Declining or Waning

While the journal continues to thrive in many areas, certain themes have shown a decline in emphasis, reflecting shifts in research priorities and advancements in urologic oncology.
  1. Traditional Surgical Techniques:
    There has been a noticeable decrease in publications focusing solely on traditional surgical approaches, as the field increasingly emphasizes minimally invasive and robotic-assisted techniques.
  2. Basic Science Research:
    The journal has seen a waning interest in purely basic science studies, particularly those not directly linked to clinical applications or translational research.
  3. Single-modality Treatments:
    Research focusing exclusively on single-modality treatments (e.g., surgery or radiation alone) is appearing less frequently, as the trend shifts towards multimodal and personalized treatment approaches.

Similar Journals

Current Urology

Your Resource for Cutting-Edge Urological Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1661-7649Frequency: 4 issues/year

Current Urology, published by Lippincott Williams & Wilkins, is a leading journal dedicated to advancing the fields of urology, oncology, and reproductive medicine. With an ISSN of 1661-7649 and E-ISSN of 1661-7657, this journal has established itself as a valuable resource for researchers, practitioners, and students alike, providing peer-reviewed articles that contribute to the ongoing discourse and development of these critical specialties. Operating out of the United States, Current Urology ranks in the third quartile for oncology, reproductive medicine, and urology, reflecting its importance in the medical community. The journal’s focus on innovative research and clinical practice allows it to bridge gaps between theoretical understanding and practical application, enhancing patient care and outcomes. Although currently not an open-access journal, it offers a wealth of insights and findings that underpin contemporary urological practices and research. In an evolving medical landscape, Current Urology remains an essential platform for disseminating knowledge and fostering collaboration among experts in the field.

American Journal of Clinical and Experimental Urology

Advancing urological science through innovative research.
Publisher: E-CENTURY PUBLISHING CORPISSN: 2330-1910Frequency: 1 issue/year

American Journal of Clinical and Experimental Urology is a pivotal platform for the dissemination of cutting-edge research in the field of urology. Published by E-CENTURY PUBLISHING CORP, this peer-reviewed journal aims to enhance the understanding and application of clinical and experimental practices in urological science. The journal prioritizes high-quality, original research articles, reviews, and case studies that provide valuable insights for urologists, researchers, and healthcare professionals alike. With an increasing focus on evidence-based approaches to urological health, AJCEU serves as an essential resource for those who strive to advance diagnostic and therapeutic methodologies. Though currently not indexed in major databases, the journal is committed to expanding its reach within the academic community, thus fostering collaboration and innovation in urology. The open access model allows for broader distribution and engagement with the latest findings in the field, making it an indispensable tool for scholars and practitioners dedicated to advancing urological care and research.

BJU INTERNATIONAL

Connecting Global Experts for Urological Excellence
Publisher: WILEYISSN: 1464-4096Frequency: 12 issues/year

BJU International is a prestigious academic journal specializing in the field of Urology, published by WILEY, one of the leading publishers in scientific literature. With an impressive impact factor and recognized as a Q1 journal in Urology for 2023, it ranks #7 out of 120 in the Scopus Medicine _ Urology category, placing it in the 94th percentile among its peers. Established in 1929 and with converged years from 1994 to 2024, BJU International provides a platform for groundbreaking research, clinical studies, and advancements in urological science. The journal is accessible in both print and online formats, catering to a global audience dedicated to enhancing urological practice and research. By fostering interdisciplinary dialogue and disseminating high-quality studies, BJU International plays a crucial role in advancing knowledge and improving patient care in the field of urology.

UROLOGY

Advancing Urological Knowledge for Tomorrow's Care
Publisher: ELSEVIER SCIENCE INCISSN: 0090-4295Frequency: 12 issues/year

UROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.

Urology Annals

Connecting Innovators in Urology for a Healthier Tomorrow.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0974-7796Frequency: 6 issues/year

Urology Annals, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to advancing the field of urology through high-quality research and clinical insights. Established in India in 2009, this journal serves as a vital platform for communication among urologists, researchers, and medical professionals, aiming to enhance understanding and innovation in urological sciences. With an ISSN of 0974-7796 and an E-ISSN of 0974-7834, the journal offers unrestricted access to its content, fostering knowledge dissemination and collaboration across the global medical community. Currently ranked in the Q3 category within urology and holding a Scopus rank of #79/120, Urology Annals showcases significant contributions that align with its mission to publish original research, reviews, and case reports that address contemporary challenges in urology. The journal's ongoing commitment to remaining a leading resource in the field is reflected through its convergence of years from 2010 to 2024, ensuring that it stays at the forefront of the latest urological advancements.

African Journal of Urology

Engaging Minds, Enhancing Urological Practices
Publisher: SPRINGERISSN: 1110-5704Frequency: 1 issue/year

African Journal of Urology (ISSN: 1110-5704, E-ISSN: 1961-9987) is a leading scholarly publication in the field of urology, published by SPRINGER from the United Kingdom. Since adopting an open access model in 2012, this journal has aimed to increase the visibility and dissemination of vital research findings across the African continent and beyond. With a current impact factor and significant standing, as denoted by its Q3 ranking in Urology for 2023, it serves as an essential platform for clinicians, researchers, and students alike. The journal's scope encapsulates all aspects of urology, fostering advancements in both clinical practices and innovative research while specifically addressing healthcare challenges relevant to African populations. As part of its commitment to accessibility and academic excellence, the journal offers full open access to its content, allowing for a broad readership and engagement with cutting-edge studies. Engage with the African Journal of Urology to contribute to and stay informed about vital developments in urological science.

International Braz J Urol

Unlocking Innovations in Urological Health
Publisher: BRAZILIAN SOC UROLISSN: 1677-5538Frequency: 6 issues/year

International Brazilian Journal of Urology, published by the Brazilian Society of Urology, is a distinguished open-access journal that has been contributing to the field of urology since 2003. This journal plays a vital role in disseminating high-quality research and advancements in various aspects of urological science and medicine, targeting an international audience of researchers, practitioners, and students. With an impressive ranking in the 2023 Scopus metrics, securing Q2 status in both Medicine (Miscellaneous) and Urology, it stands as a significant resource for emerging trends and discoveries in these areas. The journal’s commitment to accessibility, with open access since its inception, ensures that valuable findings are readily available to the global medical community. Situated in Rio de Janeiro, Brazil, the International Brazilian Journal of Urology not only enhances academic discourse but also fosters collaboration across borders and specialties, making it a pivotal platform for advancing urological research.

Journal of Urological Surgery

Advancing Urological Excellence Through Open Access Research
Publisher: GALENOS PUBL HOUSEISSN: 2148-9580Frequency: 4 issues/year

Journal of Urological Surgery, published by GALENOS PUBL HOUSE, is a premier open access journal dedicated to the evolving field of urology. With its commitment to accessible knowledge since 2014, the journal aims to disseminate cutting-edge research, case studies, and innovative practices related to urological surgery, making it a vital resource for researchers, clinicians, and students alike. While it is currently indexed in key databases, the journal also seeks to strengthen its impact factor, reflecting its growing significance in the medical community. Based in Istanbul, Turkey, the Journal of Urological Surgery not only addresses critical advancements in surgical techniques and patient care but also encourages collaborative discussions within the field, making it an essential platform for those looking to stay at the forefront of urological innovations.

Prostate Cancer

Empowering discoveries in urology and oncology.
Publisher: HINDAWI LTDISSN: 2090-3111Frequency: 1 issue/year

Prostate Cancer is a leading peer-reviewed Open Access journal published by HINDAWI LTD, dedicated to advancing the field of urology and oncology through high-quality research and innovative studies. Established in 2011, this journal serves as a vital platform for disseminating findings related to prostate cancer diagnostics, treatment strategies, and patient care, striving to collaborate and connect researchers from around the globe. With an impact factor reflective of its critical input in the scientific community, the journal showcases compelling manuscripts, reviews, and case reports that are accessible to a wide audience given its open access policy. Located in London, England, Prostate Cancer has made significant strides in its category quartiles, achieving Q4 in Cancer Research and Q3 in both Oncology and Urology as of 2023, reflecting its growing relevance and readership. With Scopus rankings indicating its position within the broader medical fields, the journal is a valuable resource for researchers, professionals, and students alike, contributing to the collective effort to improve outcomes in prostate cancer research and treatment.

WORLD JOURNAL OF UROLOGY

Delivering Impactful Research in Urology
Publisher: SPRINGERISSN: 0724-4983Frequency: 12 issues/year

WORLD JOURNAL OF UROLOGY, published by Springer, stands as a premier journal in the field of urology, holding a commendable Q1 ranking in the 2023 category quartiles. With an ISSN of 0724-4983 and an E-ISSN of 1433-8726, this journal has been a vital resource since its inception in 1983, and continues to influence research up to 2024. Its ranking of 13th out of 120 in the Scopus Medicine Urology category, placing it in the 89th percentile, reflects its significant impact within the academic community. The journal aims to publish cutting-edge research, reviews, and clinical studies that advance knowledge in urological science and practice. Although it features no open access options, its rigorous peer-review process ensures that only the highest quality studies are disseminated, catering to a wide audience of researchers, medical professionals, and students eager to stay at the forefront of urological advancements.